CareCloud stock rises 70% in Q2, tops Russell Microcap gainers.

• CareCloud's stock rose 70% in Q2 2025 • Among top gainers in the Russell Microcap Index • Added to the Russell Microcap Index on June 30, 2025 • Reflects investor confidence in strategic direction • Growing visibility and AI innovation • Strengthened balance sheet and expanded public float • Renewed focus on targeted acquisitions and capital structure enhancement

Somerset, N.J., July 2, 2025 (GLOBE NEWSWIRE) – CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and revenue cycle management solutions, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index [1]. The company was officially added to the index on June 30, 2025.

This significant performance reflects growing investor confidence in CareCloud's strategic direction, particularly as the company accelerates AI innovation, re-engages in targeted acquisitions, and enhances its capital structure. The inclusion in the Russell Microcap Index underscores CareCloud's growing visibility and investor confidence in its strategic direction.

Key developments driving CareCloud's strong performance include the launch of an AI Center of Excellence, resumed M&A activities, and a healthy cash position of over $10 million. Additionally, the conversion of 3.5 million Series A Preferred shares into Common Stock has further strengthened the company's balance sheet and expanded its public float.

Stephen Snyder, Co-CEO of CareCloud, commented on the company's performance, stating, "Our performance this quarter reflects growing investor confidence in our strategic direction, particularly as we accelerate AI innovation, re-engage in targeted acquisitions, and enhance our capital structure. With a strengthened balance sheet, an expanding public float, and a renewed focus on delivering intelligent health solutions, we believe CareCloud is well positioned for long-term growth."

The first half of 2025 highlights CareCloud's disciplined execution and positions the company for continued momentum into the second half of the year. CareCloud's comprehensive suite of revenue cycle, practice management, and patient engagement solutions, supported by emerging AI technologies, continues to improve clinical and financial outcomes for medical practices and health systems.

For additional information, please visit CareCloud's website at carecloud.com or their investor relations page at ir.carecloud.com.

References:
[1] https://stockanalysis.com/stocks/ccld/